Investor Presentation
Filed with ASX · · 27 pages · English
Summary by 6ix AI
PainChek Ltd has released an investor presentation detailing its progress and future plans for its pain assessment technology. The presentation highlights the company's achievements, including a significant number of contracted licenses and a strong pipeline for growth. PainChek is targeting entry into the US market with its FDA-cleared adult app and plans to launch its infant app in various markets. The company reports consistent growth in clinical utility and aims to expand its presence in senior care facilities worldwide.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from PainChek
- Notice of Annual General Meeting/Proxy Form
- Key hire to drive Infant App in $15Bn addressable market
- Response to ASX Aware Letter
- PainChek Secures First US Customer Following FDA Clearance
- PainChek FDA Cleared to Commence Sales in US$100M US Market
Later from PainChek
- AGM Presentation
- PainChek gains access to RTM reimbursement in USA
- PainChek Business Update
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Yearly Report and Accounts
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek